A detailed history of Heathbridge Capital Management Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Heathbridge Capital Management Ltd. holds 62,850 shares of ZTS stock, worth $11.1 Million. This represents 4.86% of its overall portfolio holdings.

Number of Shares
62,850
Previous 63,250 0.63%
Holding current value
$11.1 Million
Previous $11 Million 11.98%
% of portfolio
4.86%
Previous 4.85%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$172.58 - $196.48 $69,032 - $78,592
-400 Reduced 0.63%
62,850 $12.3 Million
Q2 2024

Aug 07, 2024

BUY
$145.54 - $178.83 $9.21 Million - $11.3 Million
63,250 New
63,250 $11 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Heathbridge Capital Management Ltd. Portfolio

Follow Heathbridge Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heathbridge Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Heathbridge Capital Management Ltd. with notifications on news.